Skip to main content

Plasma Protease C1-inhibitor Treatment Market Demand and Forecast Report by 2025


25th September 2018 - Global plasma protease C1-inhibitor treatment market is expected to grow at the highest CAGR in the upcoming years. C1-inhibitor is also known as C1-INH and C1 esterase inhibitor. C1-INH’s deficiency is the genetic defect underlying hereditary angioedema (HAE). Plasma protease C1-inhibitor concentrate is an effective and safe treatment for acute hereditary angioedema (HAE) attacks. The factors that play an important role in the growth of plasma protease C1-inhibitor treatment industry are prevalence of rare diseases, novel therapies, promising pipeline drugs, increasing investments in innovation of inhibitor drugs, and rising awareness regarding HAE.

Growth drivers for the plasma protease C1-inhibitor treatment market are rising practice of administering prophylactic treatment process for hereditary angioedema (HAE) patients, increasing demand for administering drugs internally among HAE patients, and new route for highly demand of C1-inhibitor drugs. This market is segmented on the basis of drug class, dosage type, distribution channel, and geography.


Based on drug class, the plasma protease C1-inhibitor treatment industry is classified as C1-inhibitors, kallikrein inhibitor (kalbitor), selective bradykinin B2 receptor antagonist (firazyr) and so on. The segment “C1-inhibitor” is sub-divided into C1-esterase inhibitor, recombinant inhibitor, and so on. Also, this segment held the highest market share in the past few years as C1-inhibitor drugs are usually used for the treatment of acute hereditary angioedema (HAE) and prophylaxis. Based on dosage type, the plasma protease C1-inhibitor treatment market is classified as liquid/injectable, lyophilized, and so on. The segment “lyophilized” held highest share in the past few years due to rising practice of intravenous administration of drugs for the treatment of HAE.

Based on distribution channel, the plasma protease C1-inhibitor treatment industry is classified as hospital pharmacies, independent pharmacies & outlets, and so on. Based on geography, the plasma protease C1-inhibitor treatment industry is classified as North America (U.S., Canada), Latin America (Brazil, Argentina, and Rest of Latin America), Europe (EU-5 Countries, BENELUX countries, Rest of Europe), and Rest of World (Israel, Australia, Rest of world countries).

Latin America and Asia Pacific are expected to control the lyophilized segment positively due to growth in high demand for intravenous C1 esterase inhibitor drugs market. Key players operating in the plasma protease C1-inhibitor treatment market are Shire plc, Sanquin, CSL Limited, Vertec Biosolvents, Somaiya Group, Pharming Group N.V., Yancheng Hongtai Bioengineering and Huade Biological Engineering. 




Comments

Popular posts from this blog

RFID Smart Cabinet Market Share, Distributor Analysis, Development Trends 2021

Global RFID smart cabinet market is segmented into standard form and customized form, based on product. RFID smart cabinet serves multiple objectives for various business domains. One of the most profound uses of RFID smart cabinets caters to hospitals and medical institutions. Using a patent protected RFID technique coupled with point-of-use reporting, smart cabinets enable a precise, real-time inventory management at the stock and inventory level. Technically, RFID smart cabinet works on RFID principle. RFID labels are placed on item package or box and the item’s barcode gets scanned to enroll into the system. Enrolled stock is then ready for placement in the smart cabinet. Individual stock is then placed on the shelves with the RFID tags facing towards the rear of cabinet. In the end, cabinet doors are closed & items are ready for use. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/rfid-smart-cabinet-market On a commercial scale, R...

Chlortetracycline (Feed Grade) Market Latest Trends & Forecasts Report By 2025

25 th January 2019 -   Global Chlortetracycline (Feed Grade) Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Chlortetracycline (CTC) Feed Grade is also termed as chlortetracycline is an antimicrobial drug effective against gram-negative and gram-positive bacterium and other pathogenic bacteria like rickettsia, chlamydia, and mycoplasma. It is exclusively used in the treatment of cholera, white dysentery, paratyphoid, enteritis, typhoid, and pneumonia in livestock and poultry. It is available as a brown to dark brown powder. It also used in animals that are usually administered in the feed for prophylactic purposes and also increases the reward of feed. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/chlortetracycline-feed-grade-market Chlortetracycline (Feed Grade) Market is segmented based on product types, applications, and region. Product t...

Sugar Sphere Market Share, Size & Competitive Insights to 2022

Global sugar sphere market is segmented on the basis of type, application and geography. Sugar spheres are also known as neutral pellets, microgranules or sugar beads, nonpareil seeds. It is produced, often by using a layered sugar-coating structure. Sugar spheres are a commonly used excipient with respect to sustained-release pellet formulations utilized in oral dosage forms. The preferably rounded sugar spheres exist closely graduated particle sizes. They are then covered with sustained release additives and the active substance. Pellets could be made into tablets or used for filling capsules, with suitable additives. To ensure uniform coating, circular shape is best-suited and pellets are good with respect to automatic dosing. Sugar spheres and cellulose spheres (celphere) are pharmaceutical samples of comparable size distributions. They are also measured using sphere recognition and image processing. The reconstructions for sugar spheres and cellulose spheres (celphere) are s...